Expression of p16INK4a and cervical infection with high-risk human papillomavirus are not related to p53 activity in cervical intraepithelial neoplasia

International Journal of Gynecological Cancer

Volumn 18, Issue 5, 2008, Pages 1060-1064

  Braganca J F ^a   Sarian, L O ^a   Pitta, D R ^a   Maito, A B ^a   Vassallo, J ^a   Pignataro, F ^a   Andrade, L A ^a   Derchain, S ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Cidade Universitaria   (Brazil)

Author keywords

Cancer; Cervical intraepithelial neoplasia; Immunohistochemistry; Tumor marker

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P53;

ADULT; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION RISK; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; VIROLOGY; VIRUS INFECTION;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 51749098988     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01148.x     Document Type: Article

References (31)

1. Oka K, Suzuki Y, Nakano T. Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone: radiotherapeutic effect and prognosis. Cancer 2000 88 : 2766 73.
2. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004 23 : 2825 37.
3. Milde-Langosch K, Albrecht K, Joram S, Schlechte H, Giessing M, Löning T. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer 1995 63 : 639 45.
4. Ekalaksananan T, Pientong C, Sriamporn S et al. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening. Gynecol Oncol 2006 103 : 62 6.
5. Troncone G, Martinez JC, Palombini L et al. Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection. J Clin Pathol 1998 51 : 754 60.
6. Giannoudis A, Herrington CS. Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low, intermediate, and high risk human papillomaviruses. Cancer 2000 89 : 1300 7.
7. Castle PE, Giuliano AR. Chapter 4: genital tract infections, cervical inflammation, and antioxidant nutrients - assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr 2003 31 : 29 34.
8. Lorenzato M, Caudroy S, Bronner C et al. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions? Hum Pathol 2005 36 : 1101 7.
9. Muñoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003 348 : 518 27.
10. Kalof AN, Evans MF, Simmons-Arnold L, Beatty BG, Cooper K. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia. Am J Surg Pathol 2005 29 : 674 9.
11. Klaes R, Benner A, Friedrich T et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002 26 : 1389 99.
12. Kim YT, Zhao M. Aberrant cell cycle regulation in cervical carcinoma. Yonsei Med J 2005 46 : 597 613.
13. Murphy N, Ring M, Heffron CC et al. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 2005 58 : 525 34.
14. Baak JP, Kruse AJ, Robboy SJ, Janssen EA, van Diermen B, Skaland I. Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. J Clin Pathol 2006 59 : 1017 28.
15. Solomon D, Davey D, Kurman R et al. Forum Group Members, Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002 287 : 2114 9.
16. Nindl I, Lorincz A, Mielzynska I et al. Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods. Clin Diagn Virol 1998 10 : 49 56.
17. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkins EJ. Histological typing of female genital tract tumors. World Health Organization - international histological classification of tumors, 2nd edn. Berlin, Germany : Springler-Verlag, 1994.
18. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria : R Foundation for Statistical Computing, 2004. ISBN 3-900051-00-3. Available at : http://R-project.org. Accessed July 9, 2007.
19. Busby-Earle RM, Steel CM, Williams AR, Cohen B, Bird CC. p53 mutations in cervical carcinogenesis-low frequency and lack of correlation with human papillomavirus status. Br J Cancer 1994 69 : 732 7.
20. Agoff SN, Lin P, Morihara J, Mao C, Kiviat NB, Koutsky LA. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003 16 : 665 73.
21. Horner SM, DeFilippis RA, Manuelidis L, DiMaio D. Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells. J Virol 2004 78 : 4063 73.
22. Wright TC Jr., Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalitie. 2001 ASCCP-sponsored Consensus Conference. J Low Genit Tract Dis 2002 6 : 127 43.
23. Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000 92 : 690 8.
24. Fiedler M, Müller-Holzner E, Viertler HP et al. High level HPV-16 E7 oncoprotein expression correlates with reduced pRb-levels in cervical biopsies. FASEB J 2004 18 : 1120 2.
25. Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2000 2 : E65 7.
26. Wang SS, Trunk M, Schiffman M et al. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol Biomarkers Prev 2004 13 : 1355 60.
27. O'Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 2006 13 : 8 15.
28. Klaes R, Friedrich T, Spitkovsky D et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001 92 : 276 84.
29. Murphy N, Ring M, Killalea AG et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 2003 56 : 56 63.
30. Skomedal H, Kristensen GB, Lie AK, Holm R. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Gynecol Oncol 1999 73 : 223 8.
31. Queiroz C, Silva TC, Alves VA et al. P16(INK4a) expression as a potential prognostic marker in cervical pre-neoplastic and neoplastic lesions. Pathol Res Pract 2006 202 : 77 83.